Guillaume Pfefer, Senda Biosciences CEO

Two years post-merg­er, Flag­ship’s Sen­da re­fines pipeline and re­plen­ish­es the bank 

Sen­da Bio­sciences will look a lit­tle dif­fer­ent than it did two years ago when Flag­ship Pi­o­neer­ing un­wrapped the bow on the ven­ture, a merg­er of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.